Last reviewed · How we verify
NCT05495529
Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors
trial testing Thermal Ablation in Radiology, Interventional in 61 participants. Completed in 11 May 2022.
31 December 2021
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nice |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 61 |
| Start date | 1 January 2013 |
| Primary completion | 31 December 2021 |
| Estimated completion | 11 May 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Thermal Ablation
Conditions studied
- Radiology, Interventional — all drugs for Radiology, Interventional →
- Liver Neoplasm — all drugs for Liver Neoplasm →
- Carcinoma, Hepatocellular (RENI) — all drugs for Carcinoma, Hepatocellular (RENI) →
- Neoplasm Metastasis — all drugs for Neoplasm Metastasis →
Sponsor
Centre Hospitalier Universitaire de Nice
Who can join
Eligibility, any sex, with Radiology, Interventional or Liver Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to analyse retrospectively the feasibility, the safety, and the efficiency, of biliary or digestive protection with room air interposition for thermal ablation of central liver tumors with high iatrogenic risk. Thermal ablation is a mini-invasive and curative treatement of liver tumors. However, it requires to be carefull about surrunding organs, such as digestive structures or central biliary tree, which can be injured if not insulated. The technique of gas interposition to protect adjacent gut is already known and validated with carbonic gas. Nevertheless, resorption of this gas is very fast, making its use tricky to keep a correct insulation during the whole thermal ablation process. Room air interposition is easy to use and can offer a slow resorption speed. Furthermore no datas are available concerning the use of room air whatever the organ protected, and the protection of central biliary tree whatever the gas used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05495529
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Thermal Ablation
Trials testing the same drug.
- NCT06815939 — Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer · NA · recruiting
- NCT05472311 — Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation · NA · recruiting
- NCT03993678 — Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. · Phase 1, PHASE2 · completed
- NCT01862718 — Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms · Phase 1 · terminated
Other recruiting trials for Radiology, Interventional
Currently open trials in the same condition.
- NCT06340178 — CT-guided Lung Biopsy Risk Optimization Method · NA · recruiting
- NCT06507085 — Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology. · recruiting
Other Centre Hospitalier Universitaire de Nice trials
Trials by the same sponsor.
- NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
- NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
- NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
- NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
- NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05495529 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
- Last refreshed: 10 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05495529.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing